OLIVIER BRANDICOURT

Insider Reports History

Location
Cambridge, MA
Signature
Olivier Brandicourt, by /s/ Peter N. Efremenko, Attorney-In-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by OLIVIER BRANDICOURT:

Company Role Class Num Shares Value Price $ Report Date Ownership
BeiGene, Ltd. Director Ordinary Shares 27,326 $6,692,137 $244.90 21 May 2025 Direct
ALNYLAM PHARMACEUTICALS, INC. Director Common Stock 775 $180,536 $232.95 08 May 2025 Direct
Vaxcyte, Inc. Director Common Stock 2,505 $115,580 $46.14 15 Jan 2026 Direct
BeiGene, Ltd. Director Share Option (Right to Buy) 22,750 21 May 2025 Direct
Vaxcyte, Inc. Director Stock Option (right to buy) 6,750 15 Jan 2026 Direct
ALNYLAM PHARMACEUTICALS, INC. Director Stock Option (right to buy) 1,558 08 May 2025 Direct
Vaxcyte, Inc. Director No securities owned. 0 01 May 2025 Direct

Insider Reports Filed by OLIVIER BRANDICOURT

Symbol Company Period Transactions Value $ Form Type Role Filing Time
PCVX Vaxcyte, Inc. 15 Jan 2026 2 $0 4 Director 16 Jan 2026, 17:08
PCVX Vaxcyte, Inc. 12 Jun 2025 2 $0 4 Director 16 Jun 2025, 18:24
ONC BeiGene, Ltd. 21 May 2025 2 $0 4 Director 22 May 2025, 19:46
ALNY ALNYLAM PHARMACEUTICALS, INC. 08 May 2025 2 $0 4 Director 12 May 2025, 16:06
PCVX Vaxcyte, Inc. 01 May 2025 1 $0 4 Director 02 May 2025, 16:28
PCVX Vaxcyte, Inc. 01 May 2025 0 $0 3 Director 02 May 2025, 16:27
ONC BeiGene, Ltd. 05 Jun 2024 2 $0 4 Director 07 Jun 2024, 17:01
ALNY ALNYLAM PHARMACEUTICALS, INC. 16 May 2024 1 $0 4 Director 20 May 2024, 16:07
ONC BeiGene, Ltd. 29 Feb 2024 1 $0 4 Director 04 Mar 2024, 17:24
ONC BeiGene, Ltd. 23 Jan 2024 0 $0 3 Director 23 Jan 2024, 17:02
ALNY ALNYLAM PHARMACEUTICALS, INC. 18 May 2023 1 $0 4 Director 19 May 2023, 16:06
ALNY ALNYLAM PHARMACEUTICALS, INC. 18 May 2022 1 $0 4 Director 20 May 2022, 16:07
ALNY ALNYLAM PHARMACEUTICALS, INC. 15 Jul 2021 1 $0 4 Director 19 Jul 2021, 16:22